{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:39:36Z","timestamp":1790804376398,"version":"4.1.0"},"reference-count":47,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,6,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Clonal hematopoiesis of indeterminate potential (CHIP) is predictive of hematological cancers and cardiovascular diseases, but the etiology of CHIP initiation and clonal expansion is unknown. Several lines of evidence suggest that proinflammatory cytokines may favor mutated hematopoietic stem cell expansion. To investigate the potential link between inflammation and CHIP, we performed targeted deep sequencing of 11 genes previously implicated in CHIP in 1887 subjects aged &amp;gt;70 years from the Montreal Heart Institute Biobank, of which 1359 had prior coronary artery disease (CAD), and 528 controls did not. We assessed association of CHIP with log transformed high-sensitivity C-reactive protein (hs-CRP), a validated biomarker of inflammation. CHIP was identified in 427 of the 1887 subjects (22.6%). CHIP mutations were more frequently identified in DNMT3A (11.6%) and TET2 (6.1%), with a higher proportion of TET2 mutations occurring in controls than in patients with CAD (9.0% vs 4.9%, P &amp;lt; .001). CHIP carriers had 21% higher hs-CRP levels compared with their noncarrier counterparts (e\u03b2 = 1.21, 95% confidence interval [CI]: 1.08 to 1.36; P = .001). A similar effect was observed in the subgroup of patients with known CAD (e\u03b2 = 1.22, 95% CI: 1.06 to 1.41; P = .005). These findings confirm the association between inflammation and CHIP. This association may open investigational avenues aimed at documenting mechanisms linking inflammation to clonal progression and ultimately supports prevention interventions to attenuate CHIP\u2019s impact on cardiovascular disease and cancer.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019000770","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T16:59:08Z","timestamp":1591203548000},"page":"2430-2438","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":87,"title":["High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5375-3749","authenticated-orcid":false,"given":"Lambert","family":"Busque","sequence":"first","affiliation":[{"name":"Research Center,"},{"name":"Hematology Division, H\u00f4pital Maisonneuve-Rosemont,"},{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, Canada;"},{"name":"Beaulieu-Saucier Pharmacogenomics Center, Montreal Heart Institute, Montreal, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1036-8100","authenticated-orcid":false,"given":"Manuel","family":"Buscarlet","sequence":"first","affiliation":[{"name":"Research Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Ayachi","sequence":"first","affiliation":[{"name":"Research Center,"},{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassamin","family":"Feroz Zada","sequence":"first","affiliation":[{"name":"Beaulieu-Saucier Pharmacogenomics Center, Montreal Heart Institute, Montreal, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Provost","sequence":"first","affiliation":[{"name":"Beaulieu-Saucier Pharmacogenomics Center, Montreal Heart Institute, Montreal, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Bourgoin","sequence":"first","affiliation":[{"name":"Research Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigina","family":"Mollica","sequence":"first","affiliation":[{"name":"Research Center,"},{"name":"Hematology Division, H\u00f4pital Maisonneuve-Rosemont,"},{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Meisel","sequence":"first","affiliation":[{"name":"Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6518-108X","authenticated-orcid":false,"given":"Reinhard","family":"Hinterleitner","sequence":"first","affiliation":[{"name":"Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bana","family":"Jabri","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8442-4393","authenticated-orcid":false,"given":"Marie-Pierre","family":"Dub\u00e9","sequence":"first","affiliation":[{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, Canada;"},{"name":"Beaulieu-Saucier Pharmacogenomics Center, Montreal Heart Institute, Montreal, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Tardif","sequence":"first","affiliation":[{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, Canada;"},{"name":"Beaulieu-Saucier Pharmacogenomics Center, Montreal Heart Institute, Montreal, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"issue":"4","key":"2020060311305882200_B1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1182\/blood.V83.4.931.931","article-title":"Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe","volume":"83","author":"Fey","year":"1994","journal-title":"Blood"},{"issue":"1","key":"2020060311305882200_B2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood.V88.1.59.59","article-title":"Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age","volume":"88","author":"Busque","year":"1996","journal-title":"Blood"},{"key":"2020060311305882200_B3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.exphem.2020.01.008","article-title":"60 Years of clonal hematopoiesis research: from X-chromosome inactivation studies to the identification of driver mutations","volume":"83","author":"Ayachi","year":"2020","journal-title":"Exp Hematol"},{"issue":"11","key":"2020060311305882200_B4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/ng.2413","article-title":"Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis","volume":"44","author":"Busque","year":"2012","journal-title":"Nat Genet"},{"issue":"26","key":"2020060311305882200_B5","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"2020060311305882200_B6","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"2020060311305882200_B7","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"issue":"6","key":"2020060311305882200_B8","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","article-title":"Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly","volume":"130","author":"Zink","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2020060311305882200_B9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"2020060311305882200_B10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"issue":"6","key":"2020060311305882200_B11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1182\/blood-2017-04-777029","article-title":"DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions","volume":"130","author":"Buscarlet","year":"2017","journal-title":"Blood"},{"issue":"4","key":"2020060311305882200_B12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1182\/blood.2019001793","article-title":"Clonal hematopoiesis in elderly twins: concordance, discordance and mortality","volume":"135","author":"Hansen","year":"2020","journal-title":"Blood"},{"issue":"4","key":"2020060311305882200_B13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1182\/blood.2019001807","article-title":"Concordance for clonal hematopoiesis is limited in elderly twins","volume":"135","author":"Fabre","year":"2020","journal-title":"Blood"},{"issue":"3","key":"2020060311305882200_B14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tem.2016.09.005","article-title":"Inflammaging and \u201cGarb-aging\u201d","volume":"28","author":"Franceschi","year":"2017","journal-title":"Trends Endocrinol Metab"},{"issue":"9","key":"2020060311305882200_B15","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/stem.2845","article-title":"Concise review: age-related clonal hematopoiesis: stem cells tempting the devil","volume":"36","author":"Busque","year":"2018","journal-title":"Stem Cells"},{"key":"2020060311305882200_B16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.exphem.2017.11.002","article-title":"An inflammatory environment containing TNF\u03b1 favors Tet2-mutant clonal hematopoiesis","volume":"59","author":"Abegunde","year":"2018","journal-title":"Exp Hematol"},{"issue":"7706","key":"2020060311305882200_B17","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41586-018-0125-z","article-title":"Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host","volume":"557","author":"Meisel","year":"2018","journal-title":"Nature"},{"issue":"16","key":"2020060311305882200_B18","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1182\/bloodadvances.2018024729","article-title":"Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis","volume":"3","author":"Cook","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"2020060311305882200_B19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"},{"key":"2020060311305882200_B20","author":"Montreal Heart Institute Hospital Biobank"},{"issue":"4","key":"2020060311305882200_B21","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/CIRCGENETICS.116.001405","article-title":"Genotype-dependent effects of dalcetrapib on cholesterol efflux and inflammation: concordance with clinical outcomes","volume":"9","author":"Tardif","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"2020060311305882200_B22","doi-asserted-by":"crossref","first-page":"12484","DOI":"10.1038\/ncomms12484","article-title":"Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults","volume":"7","author":"Young","year":"2016","journal-title":"Nat Commun"},{"issue":"4","key":"2020060311305882200_B23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.52.4.561","article-title":"Serological Reactions in pneumonia with a non-protein somatic fraction of Pneumococcus","volume":"52","author":"Tillett","year":"1930","journal-title":"J Exp Med"},{"issue":"2","key":"2020060311305882200_B24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0021-9258(17)37943-7","article-title":"Primary structure of human C-reactive protein","volume":"254","author":"Oliveira","year":"1979","journal-title":"J Biol Chem"},{"issue":"1","key":"2020060311305882200_B25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-291X(88)81056-8","article-title":"The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes","volume":"155","author":"Moshage","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"2020060311305882200_B26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4419-6612-4_15","article-title":"Pathogenic role of IL-6 combined with TNF-\u03b1 or IL-1 in the induction of acute phase proteins SAA and CRP in chronic inflammatory diseases","volume":"691","author":"Yoshizaki","year":"2011","journal-title":"Adv Exp Med Biol"},{"issue":"7277","key":"2020060311305882200_B27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/bmj.322.7277.4","article-title":"The renaissance of C reactive protein","volume":"322","author":"Pepys","year":"2001","journal-title":"BMJ"},{"issue":"3","key":"2020060311305882200_B28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/clinchem\/47.3.403","article-title":"High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease","volume":"47","author":"Rifai","year":"2001","journal-title":"Clin Chem"},{"issue":"12","key":"2020060311305882200_B29","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"issue":"2","key":"2020060311305882200_B30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.119.044362","article-title":"Genetic interleukin-6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis","volume":"141","author":"Bick","year":"2020","journal-title":"Circulation"},{"key":"2020060311305882200_B31","article-title":"Inherited causes of clonal hematopoiesis of indeterminate potential in TOPMed whole genomes","author":"Bick","journal-title":"bioRxiv"},{"issue":"7569","key":"2020060311305882200_B32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature15252","article-title":"Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"issue":"6327","key":"2020060311305882200_B33","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"2020060311305882200_B34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.exphem.2019.12.005","article-title":"Environmental influences on clonal hematopoiesis","volume":"83","author":"King","year":"2020","journal-title":"Exp Hematol"},{"issue":"6","key":"2020060311305882200_B35","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.stem.2018.10.013","article-title":"Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis","volume":"23","author":"Cai","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"10","key":"2020060311305882200_B36","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2012-02-412890","article-title":"Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-\u03b2-catenin signaling","volume":"121","author":"Zhang","year":"2013","journal-title":"Blood"},{"issue":"23","key":"2020060311305882200_B37","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1182\/blood-2015-11-679928","article-title":"Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor-treated CML stem cells","volume":"128","author":"Zhang","year":"2016","journal-title":"Blood"},{"issue":"22","key":"2020060311305882200_B38","doi-asserted-by":"crossref","first-page":"e15844","DOI":"10.1097\/MD.0000000000015844","article-title":"The inflammatory cytokine profile of myelodysplastic syndromes: a meta-analysis","volume":"98","author":"Shi","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"2020060311305882200_B39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.exphem.2019.11.008","article-title":"Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients","volume":"80","author":"Zhang","year":"2019","journal-title":"Exp Hematol"},{"issue":"12","key":"2020060311305882200_B40","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"10105","key":"2020060311305882200_B41","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"issue":"26","key":"2020060311305882200_B42","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"issue":"7714","key":"2020060311305882200_B43","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41586-018-0317-6","article-title":"Prediction of acute myeloid leukaemia risk in healthy individuals","volume":"559","author":"Abelson","year":"2018","journal-title":"Nature"},{"issue":"3","key":"2020060311305882200_B44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2018-01-829937","article-title":"Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A","volume":"132","author":"Buscarlet","year":"2018","journal-title":"Blood"},{"issue":"8","key":"2020060311305882200_B45","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","article-title":"Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1\u03b2\/NLRP3 inflammasome","volume":"71","author":"Sano","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2020060311305882200_B46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jamacardio.2018.3965","article-title":"Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure","volume":"4","author":"Dorsheimer","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2020060311305882200_B47","article-title":"Hematopoietic alterations in chronic heart failure patients by somatic mutations leading to clonal hematopoiesis [published online ahead of print 7 November 2019]","author":"Dorsheimer","journal-title":"Haematologica"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/11\/2430\/1743436\/advancesadv2019000770.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/11\/2430\/1743436\/advancesadv2019000770.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T12:49:09Z","timestamp":1616071749000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/11\/2430\/460606\/Highsensitivity-Creactive-protein-is-associated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,6,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019000770","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,3]]}}}